Flu Vaccine Act
The Flu Vaccine Act (S 3215) directs the National Institute of Allergy and Infectious Diseases (NIAID) to conduct or fund research aimed at developing a universal influenza vaccine or preventative. It authorizes $200 million annually for fiscal years 2024 through 2029 to support this research effort. The bill directly affects NIAID scientists and research institutions receiving federal funding for influenza vaccine development. It establishes a specific funding mechanism for long-term research, without creating immediate public health programs or altering existing vaccine distribution.
Bill status
in committee
1 of 4 stages cleared
Introduction
Nov 2023
Committee Review
Floor Vote
President
Introduced Nov 2, 2023
Last action Nov 2, 2023
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
2
Key actions
0
Committee
1
Nov 2, 2023
Committee
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
upper
Nov 2, 2023
Introduced
Introduced in Senate
upper
1 primary · 4 co-sponsors
Sponsors
Ask Maddy
·
AI policy assistant
Ask Maddy about S 3215
Scope: US
Hi! I can help you understand S 3215. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline